Examining the Optics of Thyroid Eye Disease - oneGRAVESvoice
Global Search
Global Search

Trusted Resources: Evidence & Education

Scientific literature and patient education texts

Back to Evidence & Education / Patient Education

Examining the Optics of Thyroid Eye Disease

key information

source: Endocrine Society

year: N/A

summary/abstract:

Thyroid eye disease (TED), also known as Graves’ orbitopathy is an autoimmune condition that affects the eye tissue. The most common cause TED is Graves’ disease. 20% of cases occur six months prior to diagnosis. Hyperthyroidism is present in 40% of cases prior to and after diagnosis.

Signs and Symptoms:
Some patients diagnosed with TED may not have any symptoms, but at least half report symptoms:
 • Eyelid retraction is the most common sign
 • Inflammation and swelling of tissue around the eye
 • Dry eyes, itchiness, increased tearing, puffiness around the eyes, redness, double vision, and light sensitivity
 • Severe cases may lead to blindness

Inactive and Active Phases:
Experts use a 7-point clinical activity score to determine if TED is in the active or inactive phases. The 7 points are eye pain, pain with eye movement, eye and eyelid redness, eyelid swelling, chemosis and caruncle edema.

read more

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Powered by

Brought to you by

Supported through an independent
educational grant by

© 2022 rareLife solutions Inc.